Howard Hughes Medical Institute

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Howard Hughes Medical Institute reported 2 stock positions worth $332.9 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 98.6% of the portfolio, followed by Purecycle Technologies (PCT, 1.4%). Its holdings were unchanged from Q4 2023.

Most Recent 13F
Q2 2026
Location
Chevy Chase, MD
CIK
0000810386
Portfolio Value
$332.9M (Q1 2024)
SEC Filing
0000950123-24-005205 ↗ filed May 15, 2024

Holdings Value

0$200.0M$400.0M$600.0M$800.0M Q1 2024: $332.9M $332.9M Q1 2024 Q2 2024: $466.2M Q2 2024 Q3 2024: $630.4M Q3 2024 Q4 2024: $568.4M Q4 2024 Q1 2025: $202.2M Q1 2025 Q2 2025: $250.9M Q2 2025 Q3 2025: $170.6M Q3 2025 Q4 2025: $174.7M Q4 2025 Q1 2026: $415.8M Q1 2026 Q2 2026: $445.4M Q2 2026

Holdings 2 stocks · $332.9M

SPY SS SPDR S&P 500 ETF Trust-US 98.61% 627,563 $328.3M No change
PCT Purecycle Technologies Inc. 1.39% 741,891 $4.6M No change

Portfolio Sells Q4 2023 → Q1 2024

None this quarter.

Portfolio Buys Q4 2023 → Q1 2024

None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 30$445.4MNVDA, AAPL, GOOGL, MSFT, TSM
Q1 2026 31$415.8MSPY, NVDA, AAPL, GOOGL, MSFT
Q4 2025 500$174.7MSPY, NVDA, AAPL, MSFT, AMZN
Q3 2025 500$170.6MSPY, NVDA, MSFT, AAPL, AMZN
Q2 2025 501$250.9MSPY, NVDA, MSFT, AAPL, AMZN
Q1 2025 2$202.2MSPY, BIOA
Q4 2024 2$568.4MSPY, BIOA
Q3 2024 2$630.4MSPY, BIOA
Q2 2024 1$466.2MSPY
Q1 2024 2$332.9MSPY, PCT